Abstract

“A CLINICAL STUDY OF SHATAVARYADI CHURNA ON RAJONIVRUTTI AVASTHA WITH SPECIAL REFERENCE TO POSTMENOPAUSAL SYNDROME”

Utpal Deb Barma and Dr. Suresh Kumar*

Abstract

The menopause is permanent cessation of menstruation at the end of reproductive life due to loss of ovarian follicular activity. The age at menopause appears to be genetically determined and is unaffected by race, socioeconomic status, age at menarche, or number of prior ovulations. Factors that are toxic to the ovary often result in an earlier age of menopause; for example, women who smoke experience an earlier menopause. Women who have had surgery on their ovaries, have had a hysterectomy, despite retention of their ovaries, may also experience early menopause. In U.K. average age for menopause is 52 (National Health Service) while in the U.S.A, it is 51 (National Institute of Aging). About 1/5th women in India experience menopause before the age in 41, but average age is 50 years and about 10% women seek medical advice during menopause. Premature ovarian failure is defined as menopause before the age of 40 years. It may be idiopathic or associated with toxic exposure, chromosomal abnormality, or autoimmune disorder. Shatavaryadi Churna’ drug is 6grams twice daily before meal with milk for 2 months given. It is effective in the management of Postmenopausal Syndrome. ‘Shatavaryadi Churna’ is also effective, safe, promising and cost effective remedy.

Keywords: Rajonivrutti, Postmenopausal Syndrome, Shatavaryadi Churna.